Why the study?
To evaluate left ventricular systolic function and cardiac biomarker levels in patients with type 2 diabetes presenting with STEMI, and to correlate these biomarkers with left ventricular ejection fraction.
Does type 2 diabetes mellitus affect the correlation between cardiac biomarkers and left ventricular ejection fraction in patients with STEMI after pPCI?
Does type 2 diabetes mellitus affect the correlation between cardiac biomarkers and left ventricular ejection fraction in patients with STEMI after pPCI?
Troponin and CK levels negatively correlate with left ventricular ejection fraction 5 days after primary PCI in STEMI patients, particularly those with type 2 diabetes.
Answers are grounded in this paper and cite their sources.
May support early EF estimation via biomarkers in diabetic STEMI post-pPCI; leaves open prospective validation and outcome impact.
Aim To determine a status of systolic function in patients with diabetes mellitus (DM) type 2 with ST-segment elevation acute myocardial infarction (STEMI), to determine values of cardiac biomarkers in patients with DM type 2 with STEMI and correlate the parameters with ejection fraction of left ventricle (EFLV). Methods A total of 80 patients were divided into two groups, the study group (group I) consisting of 40 patients admitted with the diagnosis of DM type 2 and STEMI, and a control group (group II) with 40 patients with STEMI without diagnosed DM type 2. Cardiac biomarkers-creatine kinase MB fraction (CKMB), and troponin I were monitored. The EFLV was evaluated echocardiographically (using Simpson method) five days after primary percutaneous coronary intervention (pPCI). Results In the group I the EFLV five days after pPCI was significantly correlated with troponin values (with a minimum r =-0.47; p=0.002, a maximum r =-0.339; p = 0.032, as well as with an average value of r =-0.389; p=0.013), and with an average CK value (r =-0.319; p=0.045). In the group II there was a significant negative correlation of EFLV with the maximum value of troponin (r =-0.309; p=0.05). Conclusion Troponin values have an effect on the EFLV after STEMI, and thus on the left ventricular status, as well as on the pharmacological modality itself.
No takes yet. Share an insight, caveat, or question.
Halilčević et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: